Shares of German biotechnology company CureVac nearly third in their Nasdaq debut Friday, marking the first stock market debut of a company developing a potential vaccine to combat the new coronavirus. The stock opened at $ 44 per share, up from the initial public offering price of $ 16 per …
Read More »Indian clinical research body defends schedule for coronavirus vaccine trials
MUMBAI (Reuters) – India’s leading clinical research agency said on Saturday that its decision to accelerate the development of a possible coronavirus vaccine was in line with international standards, after health experts expressed concern about the clinical trial schedule. FILE PHOTO: Small bottles labeled with “Vaccine” stickers are placed near …
Read More »